Pfizer withdraws application for emergency use of its Covid vaccine in India

According to government sources, while Pfizer had sought clinical trial waiver for its vaccine, the SEC did not considered its proposal and insisted on a bridging study that it opined should be conducted on Indian population.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3cGFJN1
via IFTTT